Tactile Systems Technology (TCMD) Cash from Operations (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.96% |
| Dec 31, 2025 | 67.26% |
| Sep 30, 2025 | -29.92% |
| Jun 30, 2025 | 3,438.85% |
| Mar 31, 2025 | -97.45% |
| Dec 31, 2024 | 59.25% |
| Sep 30, 2024 | -21.96% |
| Jun 30, 2024 | 1,322.29% |
| Mar 31, 2024 | -94.97% |
| Dec 31, 2023 | 348.05% |
| Sep 30, 2023 | -70.55% |
| Jun 30, 2023 | 2,870.72% |
| Mar 31, 2023 | -113.02% |
| Dec 31, 2022 | 71.03% |
| Sep 30, 2022 | -2.25% |
| Jun 30, 2022 | 171.93% |
| Mar 31, 2022 | -157.19% |
| Dec 31, 2021 | 629.87% |
| Sep 30, 2021 | 5.28% |
| Jun 30, 2021 | -39.63% |
| Mar 31, 2021 | -115.88% |
| Dec 31, 2020 | -12.14% |
| Sep 30, 2020 | 164.52% |
| Jun 30, 2020 | -1,077.89% |
| Mar 31, 2020 | 921.35% |
| Dec 31, 2019 | -94.33% |
| Sep 30, 2019 | 472.04% |
| Jun 30, 2019 | -133.15% |
| Mar 31, 2019 | -76.08% |
| Dec 31, 2018 | 4.72% |
| Sep 30, 2018 | 556.72% |
| Jun 30, 2018 | 135.62% |
| Mar 31, 2018 | -152.25% |
| Dec 31, 2017 | 36.45% |
| Sep 30, 2017 | 212.93% |
| Jun 30, 2017 | -754.11% |
| Mar 31, 2017 | -111.72% |
| Dec 31, 2016 | -26.41% |
| Sep 30, 2016 | 140.01% |
| Jun 30, 2016 | 278.39% |
| Mar 31, 2016 | -133.37% |
| Dec 31, 2015 | 533.33% |